News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
494,250 Results
Type
Article (29374)
Company Profile (359)
Press Release (464507)
Multimedia
Podcasts (92)
Webinars (16)
Section
Business (135849)
Career Advice (427)
Deals (24622)
Drug Delivery (80)
Drug Development (66637)
Employer Resources (67)
FDA (12297)
Job Trends (9970)
News (238456)
Policy (19284)
Tag
Academia (1824)
Academic (1)
Accelerated approval (11)
Adcomms (20)
Allergies (99)
Alliances (37126)
ALS (123)
Alzheimer's disease (1395)
Antibody-drug conjugate (ADC) (210)
Approvals (12435)
Artificial intelligence (339)
Autoimmune disease (59)
Automation (18)
Bankruptcy (177)
Best Places to Work (8465)
BIOSECURE Act (15)
Biosimilars (120)
Biotechnology (262)
Bladder cancer (110)
Brain cancer (41)
Breast cancer (422)
Cancer (3358)
Cardiovascular disease (290)
Career advice (384)
Career pathing (13)
CAR-T (214)
CDC (7)
Cell therapy (580)
Cervical cancer (25)
Clinical research (56229)
Collaboration (1238)
Company closure (2)
Compensation (665)
Complete response letters (40)
COVID-19 (2059)
CRISPR (74)
C-suite (514)
Cystic fibrosis (113)
Data (3980)
Denatured (32)
Depression (89)
Diabetes (370)
Diagnostics (4998)
Digital health (27)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (164)
Drug pricing (72)
Drug shortages (16)
Duchenne muscular dystrophy (188)
Earnings (52398)
Editorial (29)
Employer branding (12)
Employer resources (61)
Events (84257)
Executive appointments (852)
FDA (14358)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1038)
Gene editing (155)
Generative AI (25)
Gene therapy (470)
GLP-1 (756)
Government (2509)
Grass and pollen (7)
Guidances (275)
Healthcare (12810)
HIV (35)
Huntington's disease (33)
IgA nephropathy (61)
Immunology and inflammation (178)
Immuno-oncology (14)
Indications (49)
Infectious disease (2224)
Inflammatory bowel disease (164)
Inflation Reduction Act (10)
Influenza (68)
Intellectual property (162)
Interviews (51)
IPO (12121)
IRA (23)
Job creations (1936)
Job search strategy (345)
Kidney cancer (12)
Labor market (33)
Layoffs (367)
Leadership (13)
Legal (3249)
Liver cancer (70)
Longevity (11)
Lung cancer (488)
Lymphoma (239)
Machine learning (26)
Management (17)
Manufacturing (472)
MASH (124)
Medical device (9153)
Medtech (9166)
Mergers & acquisitions (13279)
Metabolic disorders (890)
Multiple sclerosis (121)
NASH (17)
Neurodegenerative disease (180)
Neuropsychiatric disorders (49)
Neuroscience (2262)
NextGen: Class of 2025 (3680)
Non-profit (2674)
Now hiring (36)
Obesity (399)
Opinion (164)
Ovarian cancer (122)
Pain (114)
Pancreatic cancer (147)
Parkinson's disease (211)
Partnered (21)
Patents (325)
Patient recruitment (280)
Peanut (48)
People (43179)
Pharmaceutical (68)
Pharmacy benefit managers (7)
Phase I (17909)
Phase II (24719)
Phase III (18635)
Pipeline (2389)
Policy (131)
Postmarket research (1831)
Preclinical (7441)
Press Release (60)
Prostate cancer (176)
Psychedelics (49)
Radiopharmaceuticals (254)
Rare diseases (559)
Real estate (3688)
Recruiting (28)
Regulatory (16278)
Reports (27)
Research institute (1866)
Resumes & cover letters (47)
Rett syndrome (16)
RNA editing (15)
RSV (38)
Schizophrenia (118)
Series A (181)
Series B (130)
Service/supplier (6)
Sickle cell disease (74)
Special edition (18)
Spinal muscular atrophy (139)
Sponsored (31)
Startups (2696)
State (1)
Stomach cancer (11)
Supply chain (74)
Tariffs (34)
The Weekly (59)
Vaccines (673)
Venture capital (50)
Weight loss (251)
Women's health (40)
Worklife (3)
Date
Today (158)
Last 7 days (555)
Last 30 days (1949)
Last 365 days (26698)
2025 (21007)
2024 (30155)
2023 (33607)
2022 (43710)
2021 (46640)
2020 (42593)
2019 (32186)
2018 (24094)
2017 (24507)
2016 (22908)
2015 (26833)
2014 (20021)
2013 (15812)
2012 (16606)
2011 (16263)
2010 (14959)
Location
Africa (445)
Alabama (65)
Alaska (4)
Arizona (133)
Arkansas (11)
Asia (31589)
Australia (5469)
California (7719)
Canada (2282)
China (826)
Colorado (316)
Connecticut (313)
Delaware (235)
Europe (71351)
Florida (1053)
Georgia (270)
Hawaii (3)
Idaho (35)
Illinois (535)
India (45)
Indiana (378)
Iowa (13)
Japan (304)
Kansas (96)
Kentucky (17)
Louisiana (8)
Maine (39)
Maryland (959)
Massachusetts (6047)
Michigan (261)
Minnesota (381)
Mississippi (4)
Missouri (87)
Montana (28)
Nebraska (12)
Nevada (72)
New Hampshire (57)
New Jersey (2233)
New Mexico (25)
New York (2085)
North Carolina (1045)
North Dakota (9)
Northern California (3556)
Ohio (219)
Oklahoma (18)
Oregon (30)
Pennsylvania (1602)
Puerto Rico (16)
Rhode Island (34)
South America (636)
South Carolina (12)
Southern California (2983)
Tennessee (98)
Texas (1055)
United States (27804)
Utah (166)
Virginia (184)
Washington D.C. (61)
Washington State (652)
West Virginia (2)
Wisconsin (61)
Wyoming (1)
494,250 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sickle cell disease
Pfizer’s $5.4B GBT Bet Disappoints Again as Sickle Cell Therapy Fails in Phase III
Inclacumab, which Pfizer obtained in its 2022 acquisition of Global Blood Therapeutics, failed to significantly lower pain episodes in patients with sickle cell disease over the 48-week treatment period.
August 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
October 9, 2025
·
8 min read
Press Releases
DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference
September 3, 2025
·
1 min read
Press Releases
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
August 29, 2025
·
1 min read
Press Releases
Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference
August 21, 2025
·
1 min read
Press Releases
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
August 29, 2025
·
1 min read
Press Releases
Aer Therapeutics to Participate at Cantor Global Healthcare Conference 2025
August 28, 2025
·
1 min read
Press Releases
Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
August 28, 2025
·
1 min read
Press Releases
Astria Therapeutics to Present at Upcoming Cantor Global Healthcare Conference
August 28, 2025
·
1 min read
Press Releases
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
August 28, 2025
·
5 min read
1 of 49,425
Next
